AI assistant
Liquidia Corp — Director's Dealing 2023
Jan 13, 2023
31694_dirs_2023-01-13_dfbba1e6-b978-44ac-b1dd-eec6ae2a81e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Liquidia Corp (LQDA)
CIK: 0001819576
Period of Report: 2023-01-11
Reporting Person: JEFFS ROGER (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-01-11 | Common Stock | A | 289500 | — | Acquired | 496749 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-01-11 | Stock Option (Right to Buy) | $6.17 | A | 371154 | Disposed | 2033-01-11 | Common Stock (371154) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 46595 | Indirect |
| Common Stock | 1541667 | Indirect |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2: 25% of the RSUs shall vest on January 11, 2024 and the remaining RSUs shall vest ratably on a quarterly basis over three years thereafter.
F3: The options will vest ratably on a monthly basis over four years with the first vesting date to occur on February 11, 2023 and on the last day of each month thereafter.
F4: The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.
F5: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.